Hamamatsu University School of Medicine

Lipid Biomarker for Autism

Hamamatsu University School of Medicine discovered the lipid fraction (VLDL fraction) which works as a biomarker for autism. This biomarker detects autism in patients under the age of eight with great sensitivity.

We are looking for a partner who can develop simple detection method and/or kit so that the biomarker will be included in the check up for younger patients. We are also interested in developing nutrition guidance which will help patients reduce the symptoms by consuming neutral fat-rich diet.
5_35 5_8
Advantages of this biomarker:
  1. This biomarker approach enables detection of autism with 80% accuracy in patients between 5 and 8 years old.
  2. There is no biomarker successfully commercialized in the world yet.
  3. There is no biomarker, even those patented biomarkers, with comprehensive validation studies.
  4. Our further validation study is being conducted using birth cohort.
  5. This biomarker aims to be used in the infant health-check routines
  6. This biomarker approach allows early screening of autism and helps diagnose retardation. There are limited number of doctors specialized in autism, and this approach helps patients family to receive appropriate diagnosis and treatment early on.
More information is becoming available soon.
Please contact us for more information at info@infinitebio.com.
   Home | About | Service | Products | Technologies | News & Event | Contact | Japanese